RALA and posterior cortical atrophy: To increase both the sensitivity and specificity of circulating autoantibodies as biomarkers in PCa patients, we undertook a comprehensive screening of multiple anti-TAA autoantibodies in sera with PCa [20], and then optimized a combination using both anti-RalA autoantibody and PSA in immunodiagnosis of PCa.